Product NDC: | 68180-180 |
Proprietary Name: | Cefadroxil |
Non Proprietary Name: | Cefadroxil |
Active Ingredient(s): | 500 mg/1 & nbsp; Cefadroxil |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68180-180 |
Labeler Name: | Lupin Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065392 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080423 |
Package NDC: | 68180-180-08 |
Package Description: | 50 CAPSULE in 1 BOTTLE (68180-180-08) |
NDC Code | 68180-180-08 |
Proprietary Name | Cefadroxil |
Package Description | 50 CAPSULE in 1 BOTTLE (68180-180-08) |
Product NDC | 68180-180 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefadroxil |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20080423 |
Marketing Category Name | ANDA |
Labeler Name | Lupin Pharmaceuticals, Inc. |
Substance Name | CEFADROXIL |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |